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ABSTRACT 
Purpose:  Major depressive disorder (MDD) and social phobia (SP) are both common 
and highly co-occurring psychiatric disorders. This study used symptom network 
analysis approach to examine comorbidity structure and the complex symptom 
dynamics which may play a role in the co-occurrence of MDD and SP. 
Method: Data comes from the National Comorbidity Survey – Adolescent Supplement, 
a nationally representative survey of adolescents ages 13 to 18 years. This study 
examined data of adolescents with a lifetime diagnosis of MDD (n = 597), SP (n = 708), 
and adolescents with comorbid MDD and SP (n = 189). Networks were estimated by 
means of 26 symptoms from both disorders. 
Results:  All MDD and SP symptoms were involved in the network of both pure 
disorders and comorbid condition. Network structure was different between the pure 
disorders (p = .014), but not when comparing each of these disorders that have 
comorbid condition. Depressive symptoms of poor self-esteem and suicidal symptoms 
were central (i.e., showed a higher influence) in the symptom network for the pure 
disorders and for the comorbid condition. Other key symptoms in the comorbid 
condition network were two depressive symptoms: feelings of worthlessness and 
anhedonia. SP and MDD networks showed two common key SP symptoms: feeling 
uncomfortable when meeting new people and feeling uncomfortable talking to people 
do not know well. 
Conclusion: The study of symptom dynamics will provide useful targets for preventing 
the development of comorbid disorders as well as new lines of intervention to deal with 
key symptoms of psychiatric disorders. 
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1.  Introduction 
The comorbidity between major depressive disorder (MDD) and anxiety 
disorders is a rule rather than an exception (Kessler et al., 2012; Merikangas et al., 
2010). Of all the anxiety disorders, social phobia (SP) is one of the disorders that most 
frequently comorbid with MDD, and that these two disorders have also consistently 
been reported as among the most common psychiatric disorders during adolescence 
(Beesdo et al., 2007; Essau et al., 1999, 2000; Kessler et al., 2005; Ohayon and 
Schatzberg, 2010). Among adolescents with both disorders, SP precedes MDD in 
approximately 70% of the cases. Furthermore, among those with SP during 
adolescence, the risk for depression at adulthood is approximately 2-fold compared to 
those without SP (Beesdo et al., 2007). The comorbidity of SP and MDD tends to be 
associated with greater psychosocial impairment, and greater risk of relapse compared 
to when either disorder occurs alone (Essau et al., 2014; Ruscio et al., 2008). Therefore, 
understanding the underlying structure of comorbidity between these disorders could 
have important implications for their assessment and treatment.  
Despite the common comorbidity between SP and MDD, the meaning of this 
comorbidity remains unclear (Langer and Rodebaugh, 2013). Symptoms overlap 
between SP and MDD has been suggested as an explanation for their frequent 
comorbidity (Cramer et al., 2010). A novel approach to clarify the role of symptoms 
overlap in the constellation of comorbid disorder is the network approach. This 
approach focuses on individual symptoms and the associations between those symptoms 
(Borsboom and Cramer, 2013), as well as on the way in which these symptoms 
dynamically interact with one another over time (Schmittmann et al., 2013; van Bork et 
al., 2018). As such, the network approach helps to identify the unique role of each 
individual symptoms and may provide important information about the structure of 
comorbidity (Cramer et al., 2010). Symptoms are represented as nodes and the 
associations between these symptoms are represented as edges. Symptoms that bridge 
the relation between two disorders (i.e., bridge symptom) can be conceptualised as a 
stepping-stone in a pathway from one disorder to another, and that the presence of this 
symptom tends to increase the probability that an individual will develop a secondary 
disorder (Borsboom, 2008). Symptoms of multiple diagnoses can be combined into one 
network structure, which enable the patterns in which these symptoms co-occur to be 
examined (Cramer et al., 2010).  Despite the advantages of a network approach, only a 
handful of studies have thus far examined the network structure of psychiatric disorders.  
Beard et al. (2016) used network analysis to examine the relationships between 
and among MDD and anxiety (i.e., generalised anxiety disorder; GAD) symptoms using 
data of psychiatric adult patients (M = 35.00 years, SD = 13.80). Results indicated that 
anxiety and depressive symptoms were more connected within-disorder than between-
disorders. The symptoms of “sad mood” and “too much worry” were the most central 
symptom in the network (i.e., having great influence within the network), and the least 
central symptom was suicidal ideation. MDD’s motor symptom and GAD’s restlessness 
symptom were the most strongly connected items across these two disorders. More 
recently, van Loo et al. (2018) examined symptom networks among women with 
recurrent MDD (M = 44.40 years, SD = 8.90), who were then classified into subgroups 
based on their genetic risk for MDD (i.e., family history, polygenic risk score, early age 
at onset) and severe adversity (i.e., childhood sexual abuse, stressful life events). Their 
results showed similar associations between depressive symptoms across the different 
subgroups of genetic and environmental risk. Specifically, depressive symptoms of 
decreased appetite and weight loss or hopelessness and suicidal ideation, were strongly 
connected. 
  Langer et al. (2019) recently used network approach to examine symptoms 
which may play a role in the co-occurrence of SP and MDD in a group of adult women 
(aged 18-59 years); these women met criteria for SP, MDD, both disorders, or had no 
lifetime history of mental illness. The overall shape of the network shows a cluster of 
depression (including symptoms of depressed mood, worthless, and irritability) and 
social anxiety (including symptoms of fear and avoidance). The social fear node and the 
depressed mood node appeared at opposite ends of the network, suggesting that the 
connection between these two hallmark symptoms of SP and MDD, could only take 
place through other variables. Worthlessness was found to be an important bridge 
symptom given its position in the centre of the network and the strength of its 
relationship with other nodes. Two major limitations of Langer et al.’s study (2019) 
were its reliance on a very low sample size to conduct network analysis (i.e., 
approximately 30 participants in each group) and the inclusion of only women 
participants. These limitations may hinder generalisation of findings.  
Heeren et al. (2018) utilized network approach to characterize the associations 
between the core symptoms of SP (i.e., fear and avoidance of social situations) and 
depressive symptoms among adults with a primary SP (age range from 18 to 67 years 
old). Not all nodes were found to be equally important in the comorbidity between fear 
and avoidance of specific situations with comorbid depression. Fear and avoidance of 
meeting strangers, avoidance of going to party, and fear of speaking up at a meeting and 
of being the centre of attention were collectively the most influential SP nodes. Nodes 
which consisted of fear and avoidance of specific situations failed to cluster with those 
denoting comorbid depression symptoms; however, there were several bridge symptoms 
that connected SP and depression. Depression nodes that consisted of suicidal ideation, 
loss of interest, and loss of pleasure had the strongest association with SP symptoms. SP 
nodes that consisted of avoidance of participating in small groups, avoidance of going 
to a party, and fear of working had the strongest association with depressive symptoms. 
Unfortunately, this study did not consider samples with pure diagnoses (e.g., SP without 
comorbid disorders). Thus, the extent to which symptoms of comorbid disorders may 
play a significant role in the network’s structure is unknown. 
While informative, almost all the above studies are based on adult samples and 
thus it is unclear whether the findings could be generalised to adolescents. Adolescence 
constitutes a sensitive period for the development of internalising disorders, especially 
MDD and SP (Essau et al., 2014). In other words, this period may be a window of 
vulnerability in which some (vulnerability) factors may have a decisive influence on 
brain plasticity towards the emergence or exacerbation of these syndromes (Andersen, 
2003; Andersen and Teicher, 2008; Fuhrmann et al., 2015; Leussis and Andersen, 
2008). For that reason, a focus on adolescence is critical to understanding the 
developmental pathways of psychopathology development. Almost all studies that used 
the network approach to examining the comorbidity between MDD and SP have 
important methodological shortcomings that undermine the validity of their conclusions 
(e.g., small sample size, focus on female gender, lack of control of comorbid 
conditions).  
Little is known about the complex nature and interactions of symptoms or sets of 
symptoms in MDD and SP among adolescents. To fill up this gap, the present study 
aimed to examine symptom network connectivity of MDD, SP, and comorbidity 
between MDD and SP in a group of large sample of community adolescents using a 
symptom network approach. Additionally, it aimed to investigate the key symptoms in 
the symptom network structure, with a special interest in identifying central symptoms 
across pure disorders (MDD, SP) and comorbid conditions (comorbid MDD and SP).  
2. Methods 
2.1. Sample 
All analyses used data from the National Comorbidity Survey – Adolescent 
Supplement (NCS-A; Kessler et al., 2009a) which is a nationally representative survey 
of 10,123 adolescents in the United States of America (51.07% girls, mean age = 15.18, 
SD = 1.51) ages 13 to 18 years. Details of the NCS-A study design, sampling, and 
measures have been reported in several publications (Kessler et al., 2009a, b; 
Merikangas et al., 2009). 
The present study specifically examined data of adolescents with a lifetime 
diagnosis of MDD (n = 597; 63.82% girls; mean age = 15.53, sd = 1.47), SP (n = 708; 
53.38% girls; mean age = 15.25, sd = 1.50), and adolescents with both MDD and SP (n 
= 189; 58.20% girls; mean age = 15.52, sd = 1.51). Participants in each of these groups 
did not meet the criteria for any other internalising disorders (ID).  
All the participants provided a written consent to participate into the study. The 
study was approved by the institutional review boards at the University of Michigan and 
Harvard University. 
2.2. Measures 
The face-to-face interview with the adolescents was conducted using the World 
Health Organization Composite International Diagnostic Instrument, version 3.0 (WMH 
CIDI 3.0) (Kessler and Ustun, 2004). The WMH CIDI 3.0 is a fully-structured 
diagnostic interview which was modified to simplify language and to use examples that 
are more of relevance to adolescents (detailed description on these modifications has 
been provided in Merikangas et al., 2009). The major classes of DSM-IV disorders 
included in the WMH CIDI are mood disorders, anxiety disorders, behaviour disorders, 
eating disorders, and substance use disorders. Concordance of WMH CIDI and DSM-IV 
diagnoses was endorsed in Kessler et al. (2009b). The present study focuses on 
symptoms of major depressive disorder and social phobia (Table 1).  
_________________ 
Insert Table 1 here 
_________________ 
2.3. Data analysis 
The main sociodemographic characteristics of each group of adolescents (MDD, 
SP, MDD + SP) were examined by means of descriptive statistics. These 
sociodemographic characteristics were compared across these three groups using 
Student’s t tests and 2-based tests, as well as the Cohen’s d and Cramer’s V as effect 
size estimates. 
Participants with high rate of missing values (i.e., more than five items without 
response each module) were ruled out. Missing data were estimated by means of 
multiple imputation procedures (Sterne et al., 2009). Method to estimate missing data 
was weighted predictive mean matching. We set a cut-off of 10 iterations to obtain 
convergence for the solution comprising the imputed values.  
 Symptom network analysis (SNA) approach (Borsboom, 2017) was used to 
address the aims of the present study. This approach enables the examination of the 
dynamic relationships between symptoms that underlie a mental disorder. SNA provides 
a graphical summary of relationships between symptoms, which are represented as 
nodes. Edge between nodes reflects the conditional dependence relation between them 
(i.e., association between two symptoms after controlling for all other associations 
among the symptoms in the network). By implementing the Fruchterman and 
Reingold’s algorithm, the nodes with stronger correlations are placed near the centre of 
the network. Network was weighted and regularised (under regularised logistic 
regression framework) by shrinking small connections in the network, which are set to 
be exactly zero. Network estimation relied on nested Lasso regressions, by considering 
penalisation (based on a gamma hyperparameter,  = 0.25) on observation dependent 
basis, with model selection based on the extended Bayesian information criterion 
(EBIC).  
To examine the similarity of the structure of network across groups, analyses 
based on network comparison test were conducted (van Borkulo, 2018; van Borkulo et 
al., 2016) at three levels: network structure (i.e., whether the structure of both networks 
is invariant between groups), global strength (i.e., invariant overall connectivity of 
symptoms across between groups) and edge strength (i.e., whether each association 
between symptoms is invariant across groups, using a Bonferroni-Holm correction to 
prevent from multiple testing bias). Edge strength invariance was tested when the 
network structure showed no invariant between groups. Pairwise network comparisons 
(MDD network vs. SP network; MDD network vs. MDD+SP network; and SP network 
vs. MDD+SP network) were carried out, correcting the p level (.05/3 = .017) to prevent 
from multiple comparison testing. 
To examine the important role of each item within the symptom networks, 
centrality analysis was conducted. Centrality is conceptualised as the sum of the 
absolute values of all the non-zero associations within the network. A central symptom 
has more and stronger connections to other items than a peripheral symptom. According 
to the symptom network approach, highly central nodes are those of greatest importance 
in the network and the highest relevance to the disorder (McNally, 2016). Three 
centrality measures were calculated in this study: strength (i.e., sum of the edge weights 
connected to a node), betweenness (i.e., number of times that node lies on the shortest 
path between two other nodes), and expected influence (i.e., a strength centrality 
measure taking into account both positive and negative edges). 
Network robustness and accuracy were tested by difference tests of edge-
weights from the observed-data network and those estimating under non-parametric 
bootstrapping (Costenbader and Valente, 2003). The centrality stability coefficient 
(considering strength and betweenness) was used to determine the maximum proportion 
of cases that can be dropped to retain same centrality values. This coefficient should not 
be below .25 and is preferably to be above .50 (Epskamp et al., 2018).    
All the analyses were conducted using R Core Software (R Core Team, 2017), 
packages mice, qgraph, bootnet and NetworkComparisonTest. 
3. Results  
 Ten participants were excluded from the analyses due to the high rate of missing 
data (over 75% of missing data), resulting in 1484 participants who were used in all the 
analyses of the present study. Of these participants, 589 met the diagnosis of a lifetime 
SP (36.16% boys; overall age = 15.53 years, sd = 1.48), 706 met the diagnosis of a 
lifetime MDD (46.74% boys; overall age = 15.25 years, sd = 1.51), and 189 participants 
had comorbid MDD+SP (41.80% boys; overall age = 15.52 years, sd = 1.51). Table 2 
displays the sociodemographic characteristics of adolescents with MDD, SP, and 
comorbid MDD+SP. The groups differed in age, sex, race, family income, urbanicity 
and externalising disorder comorbidity. Adolescents in the MDD group comprised more 
girls and were mostly Caucasian white. Adolescents in the SP group were younger, a 
high proportion of them were from a black ethnicity; and a lower proportion of these 
adolescents (in comparison to those from the other study groups) showed a comorbid 
externalising disorder. Adolescents in the comorbid MDD + SP lived mostly in urban 
area and a high proportion of them were Hispanic. 
_________________ 
Insert Table 2 here 
_________________ 
3.1. Network estimation and centrality  
 It estimated 14389 missing values, 34.61% of total data. Distribution of data 
with imputed values showed the same data distribution as the original data (see the 
Supplementary material, Figure SF1). 
 The estimated networks for the study groups are depicted in Figure 1. All the 
symptoms of MDD and SP were present in the network constellations of the three 
groups. Network structure was similar when comparing the comorbid disorder network 
with those of the pure diagnoses network. However, network structure was different 
when comparing the MDD and SP networks (maximum norm of the all connection 
strength matrix = 0.94, p = .014). Global strength was not significantly different 
between groups in all comparisons. The association between suicidal thought and loss 
of self-confidence was significantly different when comparing the MDD network (r = 
.45) and SP network (r = .10).  The other correlations did not significantly differ 
between these networks.  
_________________ 
Insert Figure 1 here 
_________________ 
 Figure 2 shows the centrality measures for the three network constellations. 
Three depressive symptoms showed higher values in centrality measures across the 
three groups: death ideation, suicidal ideation, and loss of self-confidence. SP network 
and MDD network showed two common central symptoms, both of which were derived 
from the SP criteria: feeling uncomfortable when meeting new people and feeling 
uncomfortable talking to people you do not know well. Finally, the comorbid disorder 
network showed other depressive symptoms with high centrality values (Figure 2), 
namely, anhedonia and felt not as good as others most days.  
_________________ 
Insert Figure 2 here 
_________________ 
 Bootstrapped test revealed no differences across the edge weights in the three 
groups, as the bootstrapped confidence interval of the node strength included zero 
(Figure 3), thus, providing evidence on the network robustness for the estimated 
networks. Stability of centrality measures dropped significantly, but less steeply when 
considering strength. Specifically, stability correlation with the original centrality was 
low for the depression network (r for betweenness = .05; r for strength = .28) and social 
phobia network (r for betweenness = .12; r for strength = .36), and very low for the 
comorbid disorder network (r for betweenness = .00; r for strength = .05).  
_________________ 
Insert Figure 3 here 
_________________ 
4. Discussion 
 MDD and SP are among the most common and frequently comorbid psychiatric 
disorders in adolescence (Avenevoli et al., 2015; Ohayon and Schatzberg, 2010). This 
study aimed to shed light on the way in which symptoms dynamically interact with one 
another in comorbid conditions in adolescence. Concretely, we examined the 
relationships between symptoms of the comorbid MDD and SP. To achieve this goal, 
symptom network analysis was conducted to examine a group of adolescents with 
comorbid MDD and SP, and two groups of adolescents with pure disorders (i.e., one 
group with MDD and another group with SP without any comorbid internalising 
disorders). Another aim was to investigate the role of MDD and SP symptoms within 
the network of relationships between symptoms.  
 Our findings revealed that all the symptoms were of relevance in the symptom 
constellation of the comorbid condition, as well as in both the pure disorder conditions.  
This result provides some evidence that the co-occurring internalising symptoms have 
an overall propensity to express psychological distress inwards (Carragher et al., 2016; 
Caspi et al., 2015; Krueger et al., 1998). While it is not the focus of the present study, 
common underpinnings factors (e.g., dysregulation of emotional-processing cortical 
structures, some temperamental factors influencing both disorders) and shared genetic 
bases may be responsible for the development and maintenance of internalising 
symptoms and disorders (Burghy et al., 2012; Hettema, 2008; Sportel et al., 2011). 
However, our results also provide some evidence on boundaries between the studied 
disorders, highlighting the distinctiveness of SP and MDD as different internalising 
disorders. As shown by the network invariance test, the symptom network structure of 
both disorders differed significantly.  
 Additionally, we examined the role of MDD and SP symptoms within the 
constellation of relationships between symptoms. Surprisingly, some depressive 
symptoms were found to be highly relevant in the symptom network for the pure 
disorders (MDD, SP) as well as for the comorbid conditions (MDD+SP). In other 
words, these symptoms were bridge symptoms across conditions (i.e., with a critical 
role on disorder maintenance across conditions; McNally, 2016). Specifically, poor self-
esteem (i.e., loss of self-confidence) and suicidal symptoms (i.e., death ideation and 
suicidal ideation) were key in the networks of all three groups (MDD, SP, MDD+SP) as 
they showed high levels in centrality measures.  
 Our findings provide further support to previous findings that negative self-
views and feelings of low self-confidence act as a risk factor for the development of 
both MDD and anxiety disorders in childhood and adolescence (Sowislo and Orth, 
2013). Likewise, SP is associated with dysfunctional social relationships as a result of 
low self-esteem (Fung and Alden, 2016; Meeus, 2016). Furthermore, according to some 
authors the high comorbidity between MDD and SP may be mediated by low self-
esteem (De Jong et al., 2012; Vaananen et al., 2014). Our findings are in line with these 
results because self-confidence was identified to be a central symptom for MDD and 
SP, and that it has a great influence on the rest of symptom relationships. Langer et al. 
(2019) suggested that the relationship between self-confidence and mood instability 
were critical in the maintenance of internalising disorder due to a contagion effect on 
the rest of relationships between symptoms. 
 On the other hand, our study revealed that suicidal symptoms importantly 
contributed to the symptom constellation across groups (depression, social phobia and 
comorbid disorder). This finding showed that these symptoms have a critical influence 
on the relationship between symptoms for the three groups. Suicidal behaviour and 
ideation have been associated with depression disorder (Gili et al., 2019). Moreover, 
previous studies have consistently shown poor prognosis and treatment response among 
patients with depression who showed suicidal ideation (Asarnow et al., 2011; Vitiello et 
al., 2011). Suicidal symptoms have furthermore been found across a wide range of 
psychiatric disorders, including social phobia networks and other comorbid conditions 
(Armour et al., 2017; Boschloo et al., 2015; Bringmann et al., 2015). Heeren et al. 
(2018) found that suicidal ideation was an influential symptom in the network of 
symptoms of adults with SP and comorbid MDD. Some authors propose that suicidal 
symptoms are highly related to inability in emotion regulation, particularly in social 
situations (Arditte et al., 2016; Harris et al., 2018). Additionally, suicide deserves 
special attention in adolescence, because suicide is one of the leading causes of 
unnatural death in adolescents (Gili et al., 2019; World Health Organization, 2014). 
Suicidal ideation and suicide-related symptoms are strong predictors of committing 
suicide (Rodriguez-Cintas et al., 2018; Skinner and McFaull, 2012). For that reason, 
prevention/early intervention programmes are needed to tackle suicidal ideation and 
suicidal symptoms due to their devastating health consequences (i.e., survival risk) and 
their impact on the chronicity of the disorders.  
 Other symptoms of importance in the comorbid condition network were related 
to two depressive symptoms: feelings of worthlessness and anhedonia. We suggest that 
these symptoms were bridge symptoms that highly contribute to the maintenance of a 
comorbid MDD+SP condition (Cramer et al., 2010). The feelings of worthlessness 
symptom is related to low self-esteem and involves self-view being affected (Orchard et 
al., 2018; Ybrandt, 2008). Anhedonia in comorbid depression and social phobia 
conditions may be related to social situation avoidance; studies have shown that 
frequent social avoidance could lead to severe SP which in turn often lead to the 
development of MDD (Cummings et al., 2014; Wardenaar et al., 2012). 
 To sum up, this study provides some evidence on how symptoms of MDD, SP 
and comorbid conditions interact with one another forming a dynamic network of 
relationships. Symptom network structure was similar when comparing the symptom 
constellations of the comorbid condition with either pure MDD or SP. Self-esteem (self-
confidence) and suicidal symptoms were identified as central across networks of the 
study groups (having a great influence on the relationships between symptoms), 
probably because of problems with emotion regulation that are associated with these 
disorders. Moreover, anhedonia and feelings of worthlessness were critical in the 
comorbid MDD+SP condition, being identified as bridge symptoms.  
A major strength of this study is that it used a network analysis technique which 
could provide detailed information on the complex relations between DSM-IV 
symptoms of MDD and SP in a large number of adolescents who met the diagnoses of 
MDD and SP. Furthermore, “comorbidity controls” (i.e., participants did not have a 
diagnosis of other internalising disorder) were included in the study. 
When interpreting our findings, the limitations of the present study should be 
considered. First, the information about psychiatric symptoms was based on cross-
sectional assessment. Thus, it is not possible to draw conclusions about the temporal 
relationship between symptoms. Further research should address this issue by 
conducting longitudinal studies. Second, externalising disorder symptoms were not 
taken into account. Furthermore, other comorbid conditions (e.g., eating disorders), 
apart from comorbidity with internalising disorders, should have been controlled. 
However, our approach relied on robust frameworks considering internalising and 
externalising disorders having characteristic profiles and distinct symptoms (Krueger et 
al., 1998). Moreover, alternative strategies to deal with the confounding effect of 
comorbid conditions (e.g., sensitivity analysis removing participants with comorbid 
externalising disorders) resulted in very low sample size (some groups with n < 100) 
and biased, resulting in unreliable solutions. Thus, future research should address the 
additive effect of externalising and other syndromes within internalising symptom 
constellations. Another limitation of our study is that it did not consider adolescents 
with subclinical syndromes or adolescents with different disorder conditions according 
to symptom/disability severity. We focused on full-blown disorders regardless of 
severity to identify patterns of symptom relationships that feature pure disorders and 
encourage the development of comorbid conditions. However, future studies should 
include individuals falling in different points (stages) over the continuum of these 
internalising disorders from early-stage conditions (subclinical disorders) to severe 
conditions (chronic, unremitted conditions), and longitudinal approaches to study 
symptom-network transitions across stages. Also, robustness indicators of centrality 
measures stated that our results should be considered cautiously, even though network 
robustness estimates supported some evidence on network structure conclusions were 
valid and highly accurate. These limitations notwithstanding, this study was the first to 
have examined the associations between MDD and SP symptoms among adolescents 
with MDD, SP, and comorbid MDD + SP using the dynamic symptom network 
approach. Finally, further research should focus on other comorbidities across 
internalising disorders to delimitate particularities on symptom dynamics and 
disentangle common potential pathways of comorbidity development. 
This study has some valuable implications for clinical assessment and the search 
for effective intervention tools in adolescence. First, a wide and exhaustive assessment 
of internalising symptoms should be conducted to accurately identify patterns of 
comorbidity in adolescence and symptom-related factors that perpetuate a disorder. 
Second, when developing an intervention programme, it is important to focus on either 
central symptoms of both SP and MDD, or bridge symptoms to prevent the emergence 
of comorbid conditions.  
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Table 1.  Symptoms of depressive and social phobia as measured in the WMH CIDI 
Domain Label Item/question 
MDD D_p Small appetite most days 
 D_ch Nothing could cheer you most days 
 D_cn More trouble concentrating most days 
 D_dTH Would be better if dead 
 D_dt Often thought of death 
 D_ds Discouraged about things in life most days 
 D_n Low energy and tired w/out work most days 
 D_st Felt not as good as others most days 
 D_f Lost interest in things you used to think fun 
 D_g Felt guilty most days 
 D_h Felt hopeless about future most days 
 D_r Felt irritable/grouchy/moody most days 
 D_slf Lost self confidence 
 D_slp Trouble sleeping most nights 
 D_slw Talk/move more slowly than usual most days 
 D_sTH Slow or mixed up thoughts most days 
 D_sc Thought about suicide 
SP S_th Shy/afraid/uncomfortable talking to authority 
 S_b Shy/afraid/uncomfortable using public bathroom 
 S_d Shy/afraid/uncomfortable in dating situation 
 S_D Shy/afraid/uncomfortable disagree with people do not know well 
 S_et Shy/afraid/uncomfortable write/eat/drink while other watches 
 S_m Shy/afraid/uncomfortable being centre of attention/embarrassing situation 
 S_r Shy/afraid/uncomfortable entering room when others are present 
 S_nc Shy/afraid/uncomfortable meeting new people 
 S_nk Shy/afraid/uncomfortable talking to people do not know well 
Note. MDD = Major depressive disorder. SP = Social phobia.  
WMH CIDI = World Health Organization Composite International Diagnostic 
Instrument, version 3.0 
  
27 
 
Table 2.   Sociodemographic characteristics of the adolescents in the major depression, social phobia, and comorbid disorders (major depression 
+ social phobia) groups 
Variable  MDD SP MDD+SP χ2 (df) V 
N 589 706 189   
Age    12.56 (4)* 0.06 
Early (13-14 years) 28.18 35.55 31.22   
Mid (15-16 years) 40.58 39.94 36.51   
Late (17-18 years) 31.24 24.51 32.28   
Sex    14.76 (2)*** 0.10 
Boy 36.16 46.74 41.80   
Girl 63.84 53.26 58.20   
Race    18.22 (6)** 0.08 
White 57.56 54.96 53.97   
Hispanic 21.05 17.14 27.51   
Black 14.94 19.69 11.64   
Other 6.450 8.22 6.88   
Parents’ education    11.01 (6) 0.06 
< High school 14.94 18.56 18.52   
28 
 
High school graduate 29.54 33.43 28.04   
Some college 23.09 20.11 17.99   
College graduate 32.43 27.90 35.45   
Household income†    16.24 (6)* 0.07 
Low 15.96 16.29 22.22   
Low-average 21.56 21.39 12.70   
High-average 26.15 29.89 34.92   
High 36.33 32.43 30.16   
Urbanicity    10.04 (4)* 0.06 
Census major metropolitan area 44.31 42.64 54.50   
Other urbanised county 32.94 36.40 28.04   
Rural county 22.75 20.96 17.46   
Biological parents living with adolescent    6.04 (4) 0.04 
No parents 12.05 8.78 12.70   
One parents 38.54 39.52 42.33   
Both parents 49.41 51.70 44.97   
Comorbid externalising disorders‡ (% yes) 50.76 37.53 56.08 33.15 (2) 0.15 
Note. χ2 tests for between-category differences and related effect size estimates (Cramer’s V) are presented.  
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df = degrees of freedom. 
MDD = Major depression group; SP = Social phobia group; MDD+SP = group with comorbid depression and social phobia. 
† Levels based on poverty line. 
‡ Externalising disorders comorbidity included a lifetime diagnosis of any of these disorders: attention deficit and/or hyperactivity disorder, 
alcohol abuse or dependence, drug abuse or dependence, intermittent explosive disorder, conduct disorder, and/or oppositional defiant disorder. 
* p < .05; ** p < .01; *** p < .001. 
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Figure 1. Estimated symptom constellations for the study groups.  
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Note. Box A = Major depression network. Box B = Social phobia network. Box C = Comorbid disorder network. 
Edges represent connections between symptoms (positive partial correlations in grey or negative correlations in black). The thicker the edge, the stronger the connection. 
Nodes in grey depict social phobia symptoms. Nodes in white depict major depression symptoms. The colouring of the white circle around each node represents the explained variance by its 
neighbours. 
Symptoms: D_p = Small appetite most days. D_ch = Nothing could cheer you most days. D_cn = More trouble concentrating most days. D_dTH = Would be better if dead. D_dt = Often 
thought of death. D_ds = Discouraged about things in life most days. D_n = Low energy and tired w/out work most days. D_st = Felt not as good as others most days. D_f = Lost interest in 
things you used to think fun. D_g = Felt guilty most days. D_h = Felt hopeless about future most days. D_r = Felt irritable/grouchy/moody most days. D_slf = Lost self-confidence. D_slp = 
Trouble sleeping most nights. D_slw = Talk/move more slowly than usual most days. D_sTH = Slow or mixed up thoughts most days. D_sc = Thought about suicide. S_th = 
Shy/afraid/uncomfortable talking to authority. S_b = Shy/afraid/uncomfortable using public bathroom. S_d = Shy/afraid/uncomfortable in dating situation. S_D = Shy/afraid/uncomfortable 
disagree with people do not know well. S_et = Shy/afraid/uncomfortable write/eat/drink while other watches. S_m = Shy/afraid/uncomfortable being centre of attention/embarrassing situation. 
S_r = Shy/afraid/uncomfortable entering room when others are present. S_nc = Shy/afraid/uncomfortable meeting new people. S_nk = Shy/afraid/uncomfortable talking to people you do not 
know well. 
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Figure 2. Centrality measures across study groups.  
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Note. Green line = Major depression network. Blue line = Social phobia network. Red line = Comorbid disorder network. Measures are displayed on a relative scale from 0 (lowest) to 1 
(highest). 
Symptoms: D_p = Small appetite most days. D_ch = Nothing could cheer you most days. D_cn = More trouble concentrating most days. D_dTH = Would be better if dead. D_dt = Often 
thought of death. D_ds = Discouraged about things in life most days. D_n = Low energy and tired w/out work most days. D_st = Felt not as good as others most days. D_f = Lost interest in 
things you used to think fun. D_g = Felt guilty most days. D_h = Felt hopeless about future most days. D_r = Felt irritable/grouchy/moody most days. D_slf = Lost self-confidence. D_slp = 
Trouble sleeping most nights. D_slw = Talk/move more slowly than usual most days. D_sTH = Slow or mixed up thoughts most days. D_sc = Thought about suicide. S_th = 
Shy/afraid/uncomfortable talking to authority. S_b = Shy/afraid/uncomfortable using public bathroom. S_d = Shy/afraid/uncomfortable in dating situation. S_D = Shy/afraid/uncomfortable 
disagree with people do not know well. S_et = Shy/afraid/uncomfortable write/eat/drink while other watches. S_m = Shy/afraid/uncomfortable being centre of attention/embarrassing situation. 
S_r = Shy/afraid/uncomfortable entering room when others are present. S_nc = Shy/afraid/uncomfortable meeting new people. S_nk = Shy/afraid/uncomfortable talking to people you do not 
know well. 
 
 
